Comparing Ferric Citrate vs Ferrous Fumarate
| Ferric citrate | Ferrous fumarate |
|
|---|
| Ferric citrate | Ferrous fumarate |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hyperphosphatemia of Renal Failure, Iron Deficiency Anemia. Ferric citrate may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Iron Deficiency Anemia, Vitamin/Mineral Supplementation and Deficiency, Anemia, Anemia Due to Chronic Kidney Disease, Vitamin/Mineral Supplementation during Pregnancy/Lactation... View more |
Related suggestions Iron Deficiency Anemia
|
|||||||
| More about Ferric citrate | More about Ferrous fumarate | ||||||||
| Ratings & Reviews | |||||||||
|
Ferric citrate has an average rating of 6.4 out of 10 from a total of 8 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 38% reported a negative effect. |
Ferrous fumarate has an average rating of 5.0 out of 10 from a total of 5 ratings on Drugs.com. 20% of reviewers reported a positive effect, while 40% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Ferric citrate side effects |
View all Ferrous fumarate side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Ferric citrate prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Auryxia | Femiron, Feostat, Ferretts Iron, Ferrimin 150, Ferrocite, Fumasorb, Hemocyte, Iron Fumarate | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
N/A |
N/A |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 53 drugs are known to interact with Ferric citrate:
|
A total of 88 drugs are known to interact with Ferrous fumarate:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
September 05, 2014 |
December 01, 2014 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Carafate
Carafate is an anti-ulcer medication used to treat active duodenal ulcers. Learn about side ...
Renvela
Renvela (sevelamer) reduces blood levels of phosphorus in people with chronic kidney disease who ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Ibsrela
Ibsrela (tenapanor) is used for the treatment of irritable bowel syndrome with constipation ...
Velphoro
Velphoro (sucroferric oxyhydroxide) is used to treat hyperphosphatemia in chronic kidney disease ...
Auryxia
Auryxia is used for hyperphosphatemia of renal failure, iron deficiency anemia
Xphozah
Xphozah (tenapanor) is a phosphate absorption inhibitor that is used lower serum phosphorus levels ...
Fosrenol
Fosrenol (lanthanum carbonate) reduces phosphate levels in patients with end stage renal disease ...
Renagel
Renagel (sevelamer) is used to reduce levels of phosphorus in people with kidney disease who are on ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.